A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
Status:
Terminated
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the blood pressure lowering effects of
ramipril, an FDA-approved drug for the treatment of hypertension in adults, in children and
adolescents aged 6 to 16 years with hypertension.